Autism: Clinical Trials

6 trials for Autism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow Autism: new trials by email Literature Review of Autism trials Research Report on Autism

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)
Open-label Treatment with Omega-3 Fatty Acids + Inositol, Open-label Treatment with N-acetylcysteine - Non-verbal Learning Disorder, Autism Spectrum Disorder
Phase 4CompletedMassachusetts General Hospital542019-05-202025-06-05
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
Very Low Dose Quillivant XR, Low Dose Quillivant XR, Moderate Dose Quillivant XR - ADHD, Autism
Phase 4CompletedSeattle Children's Hospital362014-09-012017-08-01
Atomoxetine, Placebo and Parent Management Training in Autism
atomoxetine, Placebo, Parent Management Training - Autism, Pervasive Development Disorder
Phase 4CompletedUniversity of Rochester1282008-10-012016-02-04
A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
Placebo, Risperidone high dose, Risperidone low dose - Autistic Disorder, Autism
Phase 4CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.962007-12-012014-05-09
Minocycline to Treat Childhood Regressive Autism
Minocycline - Autism, Minocycline
Phase 4CompletedNational Institute of Mental Health (NIMH)112006-11-012015-12-11
Divalproex Sodium ER in Adult Autism
Divalproex Sodium ER - Autism
Phase 4CompletedMontefiore Medical Center102005-04-012018-05-31

Narrower conditions

Autistic Disorder (6)  ·  Attention Deficit Disorder with Hyperactivity (2)  ·  Aggression (1)  ·  Asperger Syndrome (1)  ·  Autism Spectrum Disorder (1)  ·  Child Development Disorders, Pervasive (1)  ·  Learning Disabilities (1)  ·  cyclopia sequence (1)

Broader conditions

Mental Disorders (6)  ·  Neurodevelopmental Disorders (6)  ·  Autism Spectrum Disorder (5)  ·  Child Development Disorders, Pervasive (5)  ·  Attention Deficit and Disruptive Behavior Disorders (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Communication Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Social Behavior (1)

Interventions

Acetylcysteine (1)  ·  Atomoxetine Hydrochloride (1)  ·  Fatty Acids, Omega-3 (1)  ·  Inositol (1)  ·  Methylphenidate (1)  ·  Minocycline (1)  ·  Risperidone (1)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)  ·  Massachusetts General Hospital (1)  ·  Montefiore Medical Center (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  Seattle Children's Hospital (1)  ·  University of Rochester (1)

Countries

United States (6)

Top investigators

Benjamin Handen, PhD (1)  ·  Eric Hollander, MD (1)  ·  Janet Wozniak, MD (1)  ·  Mark Stein, PhD (1)  ·  Michael Aman, PhD (1)  ·  Tristram Smith, PhD (1)

Results publications

PMID 37811711, PMID 20377705, PMID 23212807, PMID 23566357, PMID 24350813, PMID 26231264, PMID 26506581, PMID 27663942, PMID 29022125, PMID 29694241